In this foundational episode about drug pricing, we interview Dr. Jamie Robinson, the Leonard D. Schaeffer Professor of Health Economics, and Director of the Berkeley Center for Health Technology at the University of California, Berkeley. Dr. Robinson is the author of 3 books and 150 peer-reviewed articles on health economics and drug pricing.

James Robinson PhD, MPH, Chair, Health Policy and Management Division, Berkeley School of Public Health

Clarification on term “drug pricing”:

Nomenclature for this episode refers to the price of drugs from wholesale acquisition or list price. Other prices include the price of patient cost sharing or hospital/physician administered medication.

Biosimilars

Generics Versus Biosimilars

PBMs (Pharmacy Benefit Managers)

Do you have a prescription for better access? Share your ideas and show topics with us at [email protected]

Follow us on social media! We’re on YouTube, LinkedIn and @RX4BetterAccess (X)